Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
November 19, 2003
Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients
Taisuke Nakata, Shigemitsu Takashima, Yukimasa Shiotsu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 6, 2002
Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues
Yasuhiro Miki, Taisuke Nakata, Takashi Suzuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients
Eiji Suzuki, Rinpei Niwa, Shigehira Saji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations
Hitoshi Kiyoi, Yukimasa Shiotsu, Kazutaka Ozeki, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2008
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors
Hiroshi Ishida, Shoichi Isami, Tsutomu Matsumura, et al.
Blood
|
November 26, 2008
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
Keith W Pratz, Jorge Cortes, Gail J Roboz, et al.
Clinical Lung Cancer
|
May 30, 2018
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia
Herbert H Loong, Victoria M Raymond, Yukimasa Shiotsu, et al.
Breast Cancer Research and Treatment
|
February 3, 2007
A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models
Hiroyuki Ishida, Taisuke Nakata, Masayo Suzuki, et al.
International Journal of Oncology
|
December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
Naoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Molecular Cancer Therapeutics
|
September 27, 2012
RSK2(Ser227) at N-terminal kinase domain is a potential therapeutic target for multiple myeloma
Yuji Shimura, Junya Kuroda, Masaki Ri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
The Journal of Steroid Biochemistry and Molecular Biology
|
November 19, 2003
Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients
Taisuke Nakata, Shigemitsu Takashima, Yukimasa Shiotsu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 6, 2002
Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues
Yasuhiro Miki, Taisuke Nakata, Takashi Suzuki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients
Eiji Suzuki, Rinpei Niwa, Shigehira Saji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations
Hitoshi Kiyoi, Yukimasa Shiotsu, Kazutaka Ozeki, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2008
Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors
Hiroshi Ishida, Shoichi Isami, Tsutomu Matsumura, et al.
Blood
|
November 26, 2008
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
Keith W Pratz, Jorge Cortes, Gail J Roboz, et al.
Clinical Lung Cancer
|
May 30, 2018
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia
Herbert H Loong, Victoria M Raymond, Yukimasa Shiotsu, et al.
Breast Cancer Research and Treatment
|
February 3, 2007
A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models
Hiroyuki Ishida, Taisuke Nakata, Masayo Suzuki, et al.
International Journal of Oncology
|
December 23, 2014
Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells
Naoko Wada, Yawara Kawano, Shiho Fujiwara, et al.
Molecular Cancer Therapeutics
|
September 27, 2012
RSK2(Ser227) at N-terminal kinase domain is a potential therapeutic target for multiple myeloma
Yuji Shimura, Junya Kuroda, Masaki Ri, et al.
Page
of 3